FK
Frank Kung
OtherActiveCo-Founder and Managing Partner at VIVO Capital
80
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Frank Kung.
Investment Thesis & Strategy
Frank Kung, as a managing partner at VIVO Capital, invests in various stages of biotech, healthcare, health IT, and pharmaceutical companies, seeking to support innovative ventures within the healthcare sector.
Portfolio Companies
Selected investments from their portfolio of 80 companies
V
VYNE Therapeutics
Other · , 0
C
Coherus Biosciences
Other · , 0
S
Satsuma Pharmaceuticals
Other · , 0
A
AirXpanders
Other · , 0
G
Genetron Health
Other · , 0
B
Bristol-Myers Squibb
Other · , 0
I
INBRACE
Other · , 0
R
Revolution Medicines
Other · , 0
P
Platelet BioGenesis
Other · , 0
K
Kadmon
Other · , 0
A
Aadi Bioscience
Other · , 0
N
Neocis
Other · , 0
Frequently Asked Questions
Frank Kung focuses on Series B stage investments.